143 related articles for article (PubMed ID: 8781700)
1. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R
Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
[TBL] [Abstract][Full Text] [Related]
4. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
6. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
[TBL] [Abstract][Full Text] [Related]
7. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
8. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
9. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
[TBL] [Abstract][Full Text] [Related]
10. High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2002 Apr; 98(6):879-82. PubMed ID: 11948466
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer.
Nadji M; Fresno M; Nassiri M; Conner G; Herrero A; Morales AR
Hum Pathol; 1996 Sep; 27(9):890-5. PubMed ID: 8816882
[TBL] [Abstract][Full Text] [Related]
13. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
[TBL] [Abstract][Full Text] [Related]
14. Prognosis based on primary breast carcinoma instead of pathological nodal status.
Ménard S; Bufalino R; Rilke F; Cascinelli N; Veronesi U; Colnaghi MI
Br J Cancer; 1994 Oct; 70(4):709-12. PubMed ID: 7917924
[TBL] [Abstract][Full Text] [Related]
15. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
[TBL] [Abstract][Full Text] [Related]
16. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
17. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
18. Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma.
Spiethoff A; Schenck A; Bohrer M
J Cancer Res Clin Oncol; 2000 Dec; 126(12):707-10. PubMed ID: 11153143
[TBL] [Abstract][Full Text] [Related]
19. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
20. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
